RecruitingNot ApplicableNCT04998357

Autologous Mitochondrial Transplant for Cerebral Ischemia

Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia


Sponsor

University of Washington

Enrollment

20 participants

Start Date

Apr 29, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators propose to infuse healthy autologous mitochondria into cerebral vessels supplying brain tissue experiencing ischemia in patients who undergo standard-of- care endovascular reperfusion therapy.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Endovascular autologous mitochondrial transplantation for people with cerebral ischemia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREndovascular autologous mitochondrial transplantation

During standard-of-care endovascular reperfusion procedure, subjects will have autologous mitochondria infused via microcatheter into ischemic brain.


Locations(1)

Harborview Medical Center

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04998357


Related Trials